← Back to Search

COVID-19 Patients for Coronavirus

N/A
Waitlist Available
Research Sponsored by ProgenaBiome
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one hour
Awards & highlights
No Placebo-Only Group

Summary

Surveys administered to subjects who have recovered from COVID-19 to assess how effective their treatment was.

Eligible Conditions
  • COVID-19
  • Coronavirus
  • Coronavirus Disease
  • COVID-19 Bronchitis
  • Coronavirus Lower Respiratory Infection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one hour
This trial's timeline: 3 weeks for screening, Varies for treatment, and one hour for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Survey Response

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: COVID-19 PatientsExperimental Treatment1 Intervention
Subjects who have recovered from COVID-19

Find a Location

Who is running the clinical trial?

ProgenaBiomeLead Sponsor
45 Previous Clinical Trials
5,050 Total Patients Enrolled
Sabine Hazan, MDStudy DirectorProgenaBiome
40 Previous Clinical Trials
4,729 Total Patients Enrolled
~63 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top